Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights

The DJS Law Group reminded investors of an ongoing securities class action against Capricor Therapeutics (NASDAQ: CAPR) alleging violations of Exchange Act §§10(b), 20(a), and Rule 10b-5. The notice does not include specific new financial results or quantified damages in the excerpt. Overall, it adds incremental legal overhang risk for the stock, but the immediate market impact is likely limited based on the information provided.